AXCELIS TECHNOLOGIES INC (ACLS)

US0545402085 - Common Stock

69.47  +0.29 (+0.42%)

After market: 69.467 0 (0%)

Fundamental Rating

6

Taking everything into account, ACLS scores 6 out of 10 in our fundamental rating. ACLS was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the health and profitability get an excellent rating, making ACLS a very profitable company, without any liquidiy or solvency issues. ACLS is valued quite cheap, but it does not seem to be growing. With these ratings, ACLS could be worth investigating further for value investing!.



8

1. Profitability

1.1 Basic Checks

ACLS had positive earnings in the past year.
ACLS had a positive operating cash flow in the past year.
Each year in the past 5 years ACLS has been profitable.
ACLS had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

ACLS has a better Return On Assets (16.60%) than 88.89% of its industry peers.
ACLS has a better Return On Equity (22.76%) than 87.04% of its industry peers.
ACLS's Return On Invested Capital of 19.26% is amongst the best of the industry. ACLS outperforms 92.59% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACLS is significantly above the industry average of 11.24%.
Industry RankSector Rank
ROA 16.6%
ROE 22.76%
ROIC 19.26%
ROA(3y)16.79%
ROA(5y)12.3%
ROE(3y)24.74%
ROE(5y)17.73%
ROIC(3y)22.37%
ROIC(5y)16.23%

1.3 Margins

With a decent Profit Margin value of 20.65%, ACLS is doing good in the industry, outperforming 79.63% of the companies in the same industry.
In the last couple of years the Profit Margin of ACLS has grown nicely.
Looking at the Operating Margin, with a value of 21.87%, ACLS is in the better half of the industry, outperforming 79.63% of the companies in the same industry.
In the last couple of years the Operating Margin of ACLS has grown nicely.
With a Gross Margin value of 44.28%, ACLS perfoms like the industry average, outperforming 47.22% of the companies in the same industry.
ACLS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.87%
PM (TTM) 20.65%
GM 44.28%
OM growth 3Y24.37%
OM growth 5Y11.64%
PM growth 3Y27.39%
PM growth 5Y16%
GM growth 3Y1.27%
GM growth 5Y1.38%

8

2. Health

2.1 Basic Checks

ACLS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ACLS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ACLS has more shares outstanding
ACLS has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 6.34 indicates that ACLS is not in any danger for bankruptcy at the moment.
ACLS's Altman-Z score of 6.34 is fine compared to the rest of the industry. ACLS outperforms 66.67% of its industry peers.
ACLS has a debt to FCF ratio of 0.25. This is a very positive value and a sign of high solvency as it would only need 0.25 years to pay back of all of its debts.
ACLS has a better Debt to FCF ratio (0.25) than 84.26% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that ACLS is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.04, ACLS perfoms like the industry average, outperforming 57.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.25
Altman-Z 6.34
ROIC/WACC1.23
WACC15.6%

2.3 Liquidity

A Current Ratio of 4.45 indicates that ACLS has no problem at all paying its short term obligations.
ACLS has a Current ratio of 4.45. This is in the better half of the industry: ACLS outperforms 69.44% of its industry peers.
A Quick Ratio of 3.29 indicates that ACLS has no problem at all paying its short term obligations.
ACLS has a better Quick ratio (3.29) than 65.74% of its industry peers.
Industry RankSector Rank
Current Ratio 4.45
Quick Ratio 3.29

3

3. Growth

3.1 Past

ACLS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.29%.
Measured over the past years, ACLS shows a very strong growth in Earnings Per Share. The EPS has been growing by 40.65% on average per year.
The Revenue has decreased by -0.98% in the past year.
The Revenue has been growing by 20.63% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-3.29%
EPS 3Y76.12%
EPS 5Y40.65%
EPS Q2Q%-25.13%
Revenue 1Y (TTM)-0.98%
Revenue growth 3Y33.56%
Revenue growth 5Y20.63%
Sales Q2Q%-12.23%

3.2 Future

ACLS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.12% yearly.
Based on estimates for the next years, ACLS will show a decrease in Revenue. The Revenue will decrease by -0.85% on average per year.
EPS Next Y-19.61%
EPS Next 2Y-17.8%
EPS Next 3Y-4.12%
EPS Next 5YN/A
Revenue Next Year-9.64%
Revenue Next 2Y-6.73%
Revenue Next 3Y-0.85%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

7

4. Valuation

4.1 Price/Earnings Ratio

ACLS is valuated reasonably with a Price/Earnings ratio of 10.28.
Compared to the rest of the industry, the Price/Earnings ratio of ACLS indicates a rather cheap valuation: ACLS is cheaper than 96.30% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.73. ACLS is valued rather cheaply when compared to this.
ACLS is valuated correctly with a Price/Forward Earnings ratio of 13.84.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACLS indicates a rather cheap valuation: ACLS is cheaper than 87.96% of the companies listed in the same industry.
ACLS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.28
Fwd PE 13.84

4.2 Price Multiples

95.37% of the companies in the same industry are more expensive than ACLS, based on the Enterprise Value to EBITDA ratio.
95.37% of the companies in the same industry are more expensive than ACLS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.84
EV/EBITDA 5.01

4.3 Compensation for Growth

ACLS has an outstanding profitability rating, which may justify a higher PE ratio.
ACLS's earnings are expected to decrease with -4.12% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.25
EPS Next 2Y-17.8%
EPS Next 3Y-4.12%

0

5. Dividend

5.1 Amount

ACLS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (12/20/2024, 8:00:00 PM)

After market: 69.467 0 (0%)

69.47

+0.29 (+0.42%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners98.34%
Inst Owner Change-2.79%
Ins Owners0.56%
Ins Owner Change-0.6%
Market Cap2.26B
Analysts77.14
Price Target123.33 (77.53%)
Short Float %13.62%
Short Ratio6.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.7%
Min EPS beat(2)2.16%
Max EPS beat(2)11.25%
EPS beat(4)4
Avg EPS beat(4)10.43%
Min EPS beat(4)2.16%
Max EPS beat(4)23.88%
EPS beat(8)8
Avg EPS beat(8)14.01%
EPS beat(12)12
Avg EPS beat(12)16.55%
EPS beat(16)16
Avg EPS beat(16)17.78%
Revenue beat(2)1
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-1.37%
Max Revenue beat(2)0.47%
Revenue beat(4)3
Avg Revenue beat(4)0.81%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)2.11%
Revenue beat(8)7
Avg Revenue beat(8)2.32%
Revenue beat(12)11
Avg Revenue beat(12)2.51%
Revenue beat(16)15
Avg Revenue beat(16)2.59%
PT rev (1m)-18.45%
PT rev (3m)-20.06%
EPS NQ rev (1m)-14.17%
EPS NQ rev (3m)-43.02%
EPS NY rev (1m)-2.7%
EPS NY rev (3m)-3.41%
Revenue NQ rev (1m)-4.18%
Revenue NQ rev (3m)-23.01%
Revenue NY rev (1m)-0.96%
Revenue NY rev (3m)-1.53%
Valuation
Industry RankSector Rank
PE 10.28
Fwd PE 13.84
P/S 2.1
P/FCF 12.84
P/OCF 11.67
P/B 2.31
P/tB 2.31
EV/EBITDA 5.01
EPS(TTM)6.76
EY9.73%
EPS(NY)5.02
Fwd EY7.23%
FCF(TTM)5.41
FCFY7.79%
OCF(TTM)5.96
OCFY8.57%
SpS33.09
BVpS30.01
TBVpS30.01
PEG (NY)N/A
PEG (5Y)0.25
Profitability
Industry RankSector Rank
ROA 16.6%
ROE 22.76%
ROCE 21.67%
ROIC 19.26%
ROICexc 41.29%
ROICexgc 41.29%
OM 21.87%
PM (TTM) 20.65%
GM 44.28%
FCFM 16.35%
ROA(3y)16.79%
ROA(5y)12.3%
ROE(3y)24.74%
ROE(5y)17.73%
ROIC(3y)22.37%
ROIC(5y)16.23%
ROICexc(3y)47.16%
ROICexc(5y)32.63%
ROICexgc(3y)47.16%
ROICexgc(5y)32.63%
ROCE(3y)25.17%
ROCE(5y)18.26%
ROICexcg growth 3Y46.5%
ROICexcg growth 5Y20.84%
ROICexc growth 3Y46.5%
ROICexc growth 5Y20.84%
OM growth 3Y24.37%
OM growth 5Y11.64%
PM growth 3Y27.39%
PM growth 5Y16%
GM growth 3Y1.27%
GM growth 5Y1.38%
F-Score6
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.25
Debt/EBITDA 0.17
Cap/Depr 116.99%
Cap/Sales 1.64%
Interest Coverage 250
Cash Conversion 77.31%
Profit Quality 79.21%
Current Ratio 4.45
Quick Ratio 3.29
Altman-Z 6.34
F-Score6
WACC15.6%
ROIC/WACC1.23
Cap/Depr(3y)110.28%
Cap/Depr(5y)111.5%
Cap/Sales(3y)1.43%
Cap/Sales(5y)1.87%
Profit Quality(3y)103.53%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.29%
EPS 3Y76.12%
EPS 5Y40.65%
EPS Q2Q%-25.13%
EPS Next Y-19.61%
EPS Next 2Y-17.8%
EPS Next 3Y-4.12%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.98%
Revenue growth 3Y33.56%
Revenue growth 5Y20.63%
Sales Q2Q%-12.23%
Revenue Next Year-9.64%
Revenue Next 2Y-6.73%
Revenue Next 3Y-0.85%
Revenue Next 5YN/A
EBIT growth 1Y-3.12%
EBIT growth 3Y66.1%
EBIT growth 5Y34.67%
EBIT Next Year-17.87%
EBIT Next 3Y17.55%
EBIT Next 5YN/A
FCF growth 1Y44.92%
FCF growth 3Y29.79%
FCF growth 5Y26.35%
OCF growth 1Y47.45%
OCF growth 3Y31.05%
OCF growth 5Y27.26%